Contineum Therapeutics (CTNM) Other Accumulated Expenses (2023 - 2025)

Contineum Therapeutics' Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $50000.0 for Q3 2025.

• In Q3 2025, Other Accumulated Expenses fell 40.48% year-over-year to $50000.0; the TTM figure through Sep 2025 stood at $50000.0 (down 40.48% YoY), while the FY2024 annual figure was $124000.0, up 22.77% from the prior year.
• Other Accumulated Expenses was $50000.0 for Q3 2025 at Contineum Therapeutics, down from $109000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $2.5 million in Q1 2025 to a low of $30000.0 in Q1 2024.
• Historically, Other Accumulated Expenses has averaged $378625.0 across 3 years, with a median of $92500.0 in 2023.
• Biggest YoY gain for Other Accumulated Expenses was 8163.33% in 2025; the steepest drop was 40.48% in 2025.
• A 3-year view of Other Accumulated Expenses shows it stood at $101000.0 in 2023, then rose by 22.77% to $124000.0 in 2024, then plunged by 59.68% to $50000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $50000.0 (Q3 2025), $109000.0 (Q2 2025), and $2.5 million (Q1 2025), per Business Quant data.